Navigation

  • Feed aggregator
    • Sources
logo

Search

Primary links

  • HOME
  • ABOUT US
  • services
    • Country & Site Selection
    • Regulatory
    • Site management
    • Clinical Monitoring
    • Medical Monitoring
    • Quality Assurance & Audits
    • Medical Translations
    • Trial Performance
  • Therapeutic Experience
  • countries
  • Patients & Sites
  • case studies
    • Cardiovascular Rescue
    • Atrial Fibrillation
    • Breast Cancer
  • contact

Sources

Biospace news

  • Mylan Pharmaceuticals, Inc.'s Generic Version of Blood-Thinner Plavix Gets FDA Approval 2 days 17 hours old
  • Warner Chilcott, PLC Sues Watson Pharmaceuticals, Inc. Over Generic Contraceptive 2 days 17 hours old
  • China National Biotech Group to Raise $1.6 Billion in Hong Kong IPO 2 days 17 hours old
More

World Pharma News

  • Amgen's BiTE® antibody blinatumomab (AMG 103) achieved high rate of complete response 2 days 20 hours old
  • Merck total revenues increase 3.2% to € 2.6 billion 2 days 20 hours old
  • Pfizer provides topline results from Phase 3 study of Torisel® 3 days 20 hours old
More
Syndicate content

World Pharma News

  • Amgen's BiTE® antibody blinatumomab (AMG 103) achieved high rate of complete response
  • Merck total revenues increase 3.2% to € 2.6 billion
  • Pfizer provides topline results from Phase 3 study of Torisel®
  • In drug-approval race, US FDA ahead of Canada, Europe
  • GlaxoSmithKline to fully acquire Cellzome for £61 million
more

© 2010 S&P Pharmaterra Management